Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 with DAC Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!

How much do I take? Is this right for me? How do I use it? Is it safe? How do I know it's working? Compound Profile Scientific & Efficacy Data C165H269N47O46 Molecular Formula 3647.28 g/mol Molecular Weight 6-8 days Half-Life ~100% (subcutaneous) Bioavailabili

How much do I take?

Is this right for me?

How do I use it?

Is it safe?

How do I know it's working?

Compound Profile

Scientific & Efficacy Data

C165H269N47O46

Molecular Formula

3647.28 g/mol

Molecular Weight

6-8 days

Half-Life

~100% (subcutaneous)

Bioavailability

863288-34-0

CAS #

56841945

PubChem ID ↗

Developed By · 2005

Louis Bhardwaj

ConjuChem Biotechnology

Primary Benefits

Sustained growth hormone increase lasting 6-8 days per injection with clinically documented 2-10 fold elevation

Once or twice weekly dosing compared to daily injections required by shorter-acting peptides

Enhanced workout recovery and improved sleep quality through sustained IGF-1 elevation

Amino Acid Sequence

Dosing

How muchdo I take?

Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.

Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.

Starting Dose

1 mg (1000 mcg)

Frequency

Once weekly

Duration

2-4 weeks

A starting dose used in practice. The DAC version is long-acting (about a 6-8 day half-life), so weekly dosing keeps growth hormone and IGF-1 raised. In the Phase 1 trial a single dose raised GH for 6+ days and IGF-1 for up to 11 days. [2]

Standard Dose

2 mg (2000 mcg)

Once weekly (or split twice weekly)

8-12 weeks

The common maintenance dose, roughly in line with the 30-60 mcg/kg weekly range studied in the Phase 1 trial. [1][2]

Advanced Dose

2 mg per dose

Twice weekly

A higher total weekly amount split into two doses, used by experienced users; near the top of the 30-60 mcg/kg weekly range from the clinical study. [2]

Timing

Best time to take

Evening before bed or in the morning on an empty stomach. The extended half-life means timing is less critical than with shorter-acting peptides.

With food?

Best taken on an empty stomach or at least 2-3 hours after eating. Fats and carbohydrates can blunt the GH response.

If stacking

If combining with a GHRP like Ipamorelin, inject them together at the same time. The synergistic effect amplifies the GH pulse significantly.

Adjusting Your Dose

Increase if

+Tolerating current dose well with no significant side effects

+Not seeing expected improvements after 4-6 weeks

+IGF-1 blood levels remain in low-normal range

+Recovery and sleep benefits are minimal

Decrease if

-Experiencing significant water retention or bloating

-Joint pain or carpal tunnel symptoms appear

-Feeling excessively tired or lethargic

-Blood glucose levels becoming elevated

Signs of right dose

✓Improved sleep quality and waking refreshed

✓Better workout recovery within 24-48 hours

✓Gradual improvements in body composition

✓No significant water retention or discomfort

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Suitability

Is thisright for me?

Best For

Growth Hormone Optimization

CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile.

Muscle Building and Recovery

By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass.

Anti-Aging and Longevity

Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality.

Body Composition Improvement

The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass.

Convenient Weekly Dosing

Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols.

Consider Alternatives If

Goal: More controlled GH pulsing (mimicking natural rhythm)

Consider: CJC-1295 without DAC (Mod GRF 1-29), Sermorelin

Goal: Oral option for GH support

Consider: MK-677 (Ibutamoren), GH-releasing supplements

Goal: More potent GH release

Consider: Tesamorelin, GHRP-6 + Mod GRF 1-29 stack

Goal: Healing and recovery focus

Consider: BPC-157, TB-500, IGF-1 LR3

Who Should Avoid

Do not use if

×You have active cancer or a history of malignancy (GH may promote tumor growth)

×You are pregnant, trying to conceive, or breastfeeding

×You have pituitary tumors, disorders, or have had pituitary surgery

×You have uncontrolled diabetes or diabetic retinopathy

×You have had severe allergic reactions to GHRH analogs

×You are under 18 years of age

Use with caution if

!You have a family history of cancer

!You are taking diabetes medications (may need adjustment)

!You have carpal tunnel syndrome or are prone to it

!You have a history of edema or fluid retention issues

!You are taking thyroid medications (GH can affect thyroid function)

!You have kidney or liver disease

Not Sure?

Compare CJC-1295 with DAC with similar peptides to find the best fit for your goals.

Administration

How do Iuse it?

Reconstitution

What you need

•Bacteriostatic water (BAC water)

•Insulin syringe (29-31 gauge)

•Alcohol swabs

•Sterile vial of CJC-1295 DAC powder

Example

2mg vial + 2mL BAC water = 1mg/mL (1000mcg/mL). Each 0.1mL (10 units) = 100mcg

For 1000mcg dose at 1mg/mL concentration: draw 1.0mL (100 units on insulin syringe). For 2000mcg: draw from two vials or use a higher concentration.

Injection

Route

Subcutaneous injection

Best sites

•Abdomen (2 inches away from navel)

•Front or outer thigh

•Back of upper arm

•Lower back / love handle area

Technique

1.Clean the injection site with an alcohol swab and allow to dry completely

2.Pinch a fold of skin between your thumb and forefinger

3.Insert the needle at a 45-90 degree angle (depending on body fat)

4.Inject the solution slowly and steadily

5.Release the skin fold and withdraw the needle

6.Apply light pressure if needed - do not rub the area

Storage

Before reconstitution

Store lyophilized (freeze-dried) powder in the refrigerator at 36-46°F (2-8°C). Protect from light by keeping in original packaging or wrapped in foil. Can tolerate brief room temperature exposure during shipping.

After reconstitution

Always refrigerate after mixing with bacteriostatic water. Keep at 36-46°F (2-8°C). Never freeze reconstituted solution. Use within 28 days for best potency.

Signs of degradation

Cloudy or hazy appearance instead of clear solution

Visible particles, floaters, or clumps

Color change from clear to yellow or brown

Unusual odor

Sample Daily Schedule

Evening (before bed)

1000-2000 mcg injection

Site: Abdomen or thigh (rotate sites)

Evening dosing capitalizes on natural nighttime GH release. Take on empty stomach for best results.

Second dose mid-week (if twice weekly)

Site: Different site than first injection

Space injections 3-4 days apart (e.g., Monday and Thursday evenings) for sustained GH elevation.

Safety

Is itsafe?

Safety Profile

CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued.

Safety data comes from limited Phase 1-2 clinical trials conducted in the mid-2000s. While no serious adverse events were reported, long-term safety data is not available. The clinical development program was discontinued, so large-scale safety studies were never completed.

Common Side Effects

Experienced by some users

Injection site reactions

Redness, swelling, itching, or mild pain at injection site

Management: Rotate injection sites, apply ice before injection, ensure proper technique

Water retention

Mild bloating or puffiness, especially in hands and feet

Management: Reduce sodium intake, stay well hydrated, consider reducing dose if significant

Flushing

Temporary warmth or redness of skin, particularly face

Management: Usually subsides within 15-30 minutes, more common at higher doses

Tingling sensation

Pins and needles feeling, especially in hands

Management: Usually temporary, may indicate elevated GH - reduce dose if persistent

Less Common

•Headaches

•Fatigue or lethargy

•Joint discomfort

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Signs of allergic reaction (rash, hives, difficulty breathing, swelling)

×Persistent carpal tunnel symptoms (numbness, tingling, weakness in hands)

×Significant or unexplained swelling in hands, feet, or face

×Sudden vision changes or new joint pain that doesn't resolve

×Blood glucose becoming consistently elevated

×Discovery of any tumor or malignancy

Always consult your healthcare provider before starting, stopping, or modifying any peptide protocol. These guidelines are for educational purposes and do not constitute medical advice.

Interactions

With other peptides

✓Excellent synergy - combine for amplified GH release. Inject together.

✓Strong synergy but may increase hunger significantly. Use together if desired.

✓Good synergy for GH release. Can be combined in same injection.

!Redundant - no benefit to combining both versions.

✓Safe to combine for recovery benefits. Different mechanisms.

With medications

!Insulin - CJC-1295 DAC can raise blood glucose - may need insulin adjustment. Monitor closely.

!Diabetes medications - May counteract blood sugar lowering effects. Requires monitoring.

!Thyroid medications - GH can affect thyroid function - monitor thyroid levels.

!Corticosteroids - May blunt GH response - avoid if possible or use cautiously.

✓Blood pressure medications - Generally safe but monitor as body composition changes may affect BP.

With supplements

✓Arginine - May enhance GH release - can be taken together for added benefit.

✓Glutamine - May support GH release and recovery - safe to combine.

✓GABA - May support sleep and GH release - safe combination.

✓Melatonin - Safe to combine - may enhance sleep benefits of evening dosing.

Effectiveness

Does itwork?

Evidence Level

Moderate human trials

What to Expect

Week 1-2

What you might notice

•Mild injection site reactions (normal and temporary)

•Possible water retention or slight bloating

•May notice improved sleep quality beginning

•Some users feel slight fatigue as body adjusts

•Subtle increase in hunger in some individuals

What's normal

•Side effects like flushing or tingling are common and usually mild

•Benefits are subtle at first - GH builds up over time

•Sleep improvements are often the first noticeable effect

What's next

→Continue consistent dosing schedule

→Track sleep quality and recovery between workouts

→Note any side effects to discuss with provider if needed

Week 3-4

•Improved sleep quality becomes more consistent

•Better recovery after workouts

•Skin may start looking healthier or more hydrated

•Water retention typically stabilizes or decreases

•Energy levels may begin improving

•IGF-1 levels are building in your system

•Body composition changes are starting but may not be visible yet

•Side effects often diminish as body adapts

→Consider increasing to standard twice-weekly dosing if not already

→Continue monitoring how you feel and recover

→Maintain consistent injection schedule

Week 5-8

•More noticeable improvements in recovery time

•Possible visible changes in body composition

•Improved skin elasticity and appearance

•Consistent deeper sleep and waking refreshed

•Better performance in workouts

•Some fat loss, especially in stubborn areas

•Full effects are becoming established

•GH and IGF-1 levels are at steady elevated state

•Body has typically adapted to the peptide

→Continue current protocol if working well

→Consider lab work to check IGF-1 levels

→Assess whether dose adjustment is needed

Week 9-12+

•Sustained improvements in body composition

•Continued enhanced recovery and performance

•Maintained improvements in sleep and energy

•Possible continued gradual fat loss

•Overall sense of improved well-being and vitality

•Benefits are cumulative and continue to build

•Some users plateau and may benefit from a break

•Results vary based on diet, exercise, and individual response

→Consider a 4-8 week break after 12 weeks to prevent desensitization

→Reassess goals and whether to continue another cycle

→Maintain healthy lifestyle habits to preserve gains

Signs It's Working

Sleep and Recovery

✓Falling asleep faster and sleeping more deeply

✓Waking up feeling more refreshed and energized

✓Reduced muscle soreness after intense workouts

✓Faster recovery between training sessions

✓More vivid dreams (indicates deeper REM sleep)

Body Composition

✓Gradual reduction in body fat, especially abdominal area

✓Increased muscle fullness and definition

✓Clothes fitting differently (looser in waist, tighter in shoulders)

✓Improved muscle pumps during workouts

✓Better ability to maintain muscle during calorie restriction

Skin and Appearance

✓Improved skin hydration and elasticity

✓Reduction in fine lines or wrinkles

✓Healthier-looking complexion

✓Faster healing of minor cuts or blemishes

✓Stronger, healthier-looking hair and nails

Energy and Performance

✓More consistent energy throughout the day

✓Improved exercise endurance and capacity

✓Better mental clarity and focus

✓Increased motivation for physical activity

✓Reduced fatigue during demanding tasks

Not Seeing Results?

Common reasons

•Dose too low - consider increasing to standard 2mg twice weekly protocol

•Inconsistent dosing - the long half-life requires regular administration for sustained levels

•Not enough time - full effects take 6-8 weeks to become apparent

•Poor quality peptide - source from reputable suppliers with third-party testing

•Improper storage - degraded peptide will not work; ensure proper refrigeration

•Taking with food - fats and carbs can blunt GH release; take on empty stomach

•Unrealistic expectations - this is a gentle, gradual approach, not overnight transformation

•Lifestyle factors - poor sleep, diet, or lack of exercise can limit results

Key Research

[1]"Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog"

Jette L et al., 2005

Finding: This foundational study identified CJC-1295 as a long-lasting GHRH analog. The DAC technology allowed the peptide to bind to serum albumin, extending its presence in circulation beyond 72 hours and producing a 4-fold increase in GH release compared to native GHRH(1-29).

[2]"Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults"

Teichman SL et al., 2006

Finding: In healthy adults, a single injection of CJC-1295 increased GH levels by 2-10 fold for 6+ days and IGF-1 levels by 1.5-3 fold for 9-11 days. The half-life was 5.8-8.1 days. Multiple doses showed cumulative effects, with IGF-1 remaining elevated for up to 28 days. No serious adverse reactions were reported.

[3]"Advances in the detection of growth hormone releasing hormone synthetic analogs"

Memdouh S et al., 2021

Finding: This anti-doping research review confirmed CJC-1295's status as a prohibited substance in sports due to its potent ability to elevate GH and IGF-1 levels. The study documents the peptide's pharmacological activity and the development of detection methods.

[4]"Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography"

Ucakturk E et al., 2026

Finding: Recent analytical methods have been developed to detect CJC-1295 and other GHRH analogs in urine, demonstrating continued interest in these compounds for both clinical and anti-doping purposes.

The Science

Stacking & Combinations

Frequently Asked Questions

What's the difference between CJC-1295 with DAC and without DAC?

How long until I see results?

Should I stack CJC-1295 DAC with Ipamorelin?

Can CJC-1295 DAC help with weight loss?

Is CJC-1295 DAC the same as HGH?

Why was the clinical development discontinued?

Do I need to cycle CJC-1295 DAC?

Is CJC-1295 DAC legal?

Technical Specifications

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosages

Dosages in research are individualized and typically administered via subcutaneous injection. Common protocols include: 100 mcg per injection, 2 times per week. Cycling regimens (e.g., 8-12 weeks on, 4 weeks off) to prevent desensitization. Often dosed at bedtime to align with natural GH pulses. Dosing should be tailored to research goals and subject response, with careful monitoring.
STORAGE

Beyond Refrigeration: Other Storage Safeguards

While knowing whether does CJC-1295 need refrigeration is primary, other factors also play a significant role in peptide preservation. Light exposure, especially UV light, can accelerate degradation. Always store your peptides in opaque vials or in dark storage containers. Air, specifically oxygen, can also contribute to oxidation, another common degradation pathway. This is why vacuum-sealed packaging for lyophilized peptides and tightly sealed vials for reconstituted solutions are essential. We also recommend minimizing the number of times you open a vial to reduce air exposure and potential contamination. Every little bit helps, truly. Contamination, whether bacterial or fungal, is another silent killer of peptide integrity. Always use aseptic techniques during reconstitution and handling. This includes working in a clean environment, using sterile needles and syringes, and avoiding touching the stopper or vial opening. Our commitment to providing high-purity peptides means we've taken every step to ensure a pristine product when it leaves our facility. It's up to the researcher to maintain that standard through careful handling and storage. This meticulousness is what defines quality research, and it's a principle we champion at Real Peptides.
02

Question drills

Open a question for its connected answer.

01What If I Train Twice a Day — Does That Change the Protocol?+

No dosing adjustment needed, but timing matters. Intense resistance training triggers an acute GH pulse lasting 30–90 minutes post-session via lactate accumulation and metabolic stress. Injecting CJC-1295 within 3 hours of training means peak peptide effect overlaps with exercise-induced GH elevation, which doesn't produce additive response. Receptors are already occupied. Maintain the 60–90 minutes pre-sleep administration window regardless of training schedule. Your evening training session's GH pulse will resolve before the peptide's peak effect (2–4 hours post-injection), allowing the nocturnal surge to benefit from extended duration without interference.

SOURCE / realpeptides.co ↗
02What If my model requires pulsatile GH dynamics to match physiological rhythms — is CJC-1295 the wrong choice?+

Yes. CJC-1295 produces sustained elevation that bypasses the natural oscillatory feedback loop between GHRH release and somatostatin inhibition. If your research question involves circadian GH pulsatility, sleep-stage GH secretion, or receptor desensitization under chronic stimulation, use unmodified GHRH or a GHRP with a short half-life. CJC-1295's extended half-life is an asset for sustained-effect models but a design flaw for pulsatility research.

SOURCE / realpeptides.co ↗
03What If I Used Sterile Water Instead of Bacteriostatic Water?+

The peptide will degrade within 72–96 hours even under refrigeration. Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial growth in multi-dose vials and stabilises pH. Sterile water lacks this preservative. Meaning each time you insert a needle, you introduce potential contamination that accelerates degradation. Additionally, sterile water's neutral pH (6.5–7.5) is less stable for peptide storage than bacteriostatic water's buffered range. If you've already reconstituted with sterile water, use the entire vial within 3–4 days or discard it. For all future reconstitutions, use only bacteriostatic water.

SOURCE / realpeptides.co ↗
04What If My Fasting Glucose Rises Above 110 mg/dL During CJC-1295 Use?+

This is an expected metabolic consequence of chronic GH elevation. Growth hormone antagonises insulin action at the cellular level, reducing glucose uptake into muscle and adipose tissue. If fasting glucose rises from 90 mg/dL to 110 mg/dL, implement carbohydrate restriction (limit intake to under 150g daily), increase aerobic activity (which improves insulin sensitivity independent of GH), and retest glucose and HbA1c in four weeks. If glucose exceeds 125 mg/dL or HbA1c rises above 6.0%, discontinue CJC-1295 immediately. You're at risk for progression to overt type 2 diabetes.

SOURCE / realpeptides.co ↗
05What If the Peptide Is Dosed Too Frequently or at Excessive Amounts?+

Supraphysiological GH elevation increases insulin resistance, fluid retention, and carpal tunnel symptoms. Adverse effects documented in GH replacement studies. CJC-1295's DAC modification already extends GH secretion across days, making frequent dosing unnecessary and potentially counterproductive. Dosing above 2 mg per administration or more than twice weekly doesn't improve fat loss outcomes and may impair glucose metabolism. Our team has reviewed dozens of protocols where researchers dosed daily out of assumption that 'more is better'. Those studies showed worse metabolic markers than twice-weekly protocols despite higher total peptide exposure. Physiological pulsatility matters; chronic elevation loses the signaling advantage.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Community Research

Join others researching CJC-1295 with DAC — share findings, ask questions, and learn from real experiences Modified growth hormone releasing hormone engineered for extended duration via albumin-binding technology. DAC binds to albumin, extending half-life and providing continuous GHRH receptor stimulation. DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation.

RESEARCH

The Path from Clinical Candidate to Research Tool

The discontinuation of ConjuChem's clinical program created the conditions for CJC-1295 with DAC to become widely available as a research chemical. The compound's chemistry was described in detail in peer-reviewed publications and patents that entered the public domain. Multiple peptide synthesis laboratories began producing CJC-1295 with DAC for research use, and the compound became available through research chemical suppliers as early as the late 2000s. From a research utility standpoint, the transition from clinical candidate to tool compound was in many respects favorable. Researchers did not need to navigate clinical development constraints; they simply needed a compound with reproducible pharmacokinetics and documented biological activity for use in preclinical models. CJC-1295 with DAC met these criteria precisely. Its well-characterized albumin-binding mechanism, known half-life, and published pharmacodynamic data made it immediately useful as a tool for studying the GH axis in controlled laboratory settings.

05

Product & matchup locker

Linked catalog and comparison files.